Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124946292 | 12494629 | 2 | F | 20160715 | 20160624 | 20160722 | EXP | AU-ROCHE-1781391 | ROCHE | BUCKLEY N, DAWSON A AND ISBISTER G. TREATMENTS FOR PARACETAMOL POISONING. BMJ (ONLINE) 2016 MAY 18;353:1-5. | 24.00 | YR | F | Y | 0.00000 | 20160722 | MD | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124946292 | 12494629 | 1 | PS | DIAZEPAM. | DIAZEPAM | 1 | Oral | 13263 | |||||||||||
| 124946292 | 12494629 | 2 | SS | CARBAMAZEPINE. | CARBAMAZEPINE | 1 | Unknown | 0 | |||||||||||
| 124946292 | 12494629 | 3 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124946292 | 12494629 | 1 | Product used for unknown indication |
| 124946292 | 12494629 | 2 | Seizure |
| 124946292 | 12494629 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124946292 | 12494629 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124946292 | 12494629 | Liver function test abnormal | |
| 124946292 | 12494629 | Overdose | |
| 124946292 | 12494629 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |